Author

Lijuan Liu

Chinese Academy of SciencesORCID 0000-0002-7116-0509Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Lijuan Liu5 papers · Oregon Health & Science University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Chengxiang XiaiD· 2 shared Dehao HuangiD· 2 shared Fangxiao HuiD· 2 shared Hanmeng Qi· 2 shared Jiaxin WuiD· 2 shared Jinyong WangiD· 2 shared Leqiang ZhangiD· 2 shared Mengyun ZhangiD· 2 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Chengxiang XiaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies

Yunqing Lin, Ziyun Xiao, Fangxiao Hu, Xiujuan Zheng, Chenyuan Zhang, Yao Wang, Yanhong Liu, Dehao Huang, Zhiqian Wang, Chengxiang Xia, Qitong Weng, Leqiang Zhang, Yaoqin Zhao, Hanmeng Qi, Yiyuan Shen, , Jinyong Wang

This study generates CD7 CAR-NK cells from pluripotent stem cells that avoid fratricide and effectively suppress T-cell malignancies in xenograft models.

Journal of Hematology & Oncology · May 19, 2025Peer-reviewedCancer Biology

Pluripotent stem cell-derived NK progenitor cell therapy prevents tumour occurrence and eradicates minimal residual disease

Zhiqian Wang, Yunqing Lin, Dehao Huang, Leqiang Zhang, Chengxiang Xia, Qitong Weng, Yanhong Liu, Tongjie Wang, Mengyun Zhang, Jiaxin Wu, Hanmeng Qi, Lijuan Liu, Yiyuan Shen, Yi Chen, Yanping Zhu, , Jinyong Wang

This study develops a novel CAR-NK cell therapy using pluripotent stem cell-derived NK progenitors that persist in blood and eliminate minimal residual disease.

bioRxiv · Jan 7, 2025 · PreprintCancer Biology